ABT
Abbott Laboratories
102.60$
+0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 48.2% | 46.3% | 46.1% | 52.3% | 48.3% | 47.7% | 49.8% | 46.1% | 48.9% | 50.0% | 49.2% | 44.5% | |
| 51.8% | 53.7% | 53.9% | 47.7% | 51.7% | 52.3% | 50.2% | 53.9% | 51.1% | 50.0% | 50.8% | 55.5% | |
| 6.4% | 6.7% | 6.5% | 7.8% | 7.5% | 7.5% | 7.0% | 6.4% | 6.5% | 6.8% | 6.7% | 6.7% | |
| 32.3% | 33.3% | 32.0% | 33.3% | 31.9% | 30.6% | 28.0% | 26.3% | 25.2% | 27.9% | 27.9% | 27.9% | |
| 37.4% | 39.3% | 38.3% | 40.5% | 39.2% | 37.9% | 34.9% | 32.5% | 32.0% | 33.9% | 34.5% | 37.4% | |
| 14.4% | 14.5% | 15.6% | 7.2% | 12.6% | 14.4% | 15.3% | 21.4% | 19.2% | 16.0% | 16.3% | 18.2% | |
| 0.8% | 0.9% | 1.5% | 3.2% | 2.4% | 2.6% | 2.0% | 1.0% | 0.7% | 1.7% | 1.4% | 0.8% | |
| 12.4% | 15.6% | 6.8% | 8.1% | 9.4% | 12.8% | 14.4% | 19.1% | 19.0% | 16.6% | 16.7% | 19.1% | |
| 3.9% | 2.8% | 1.7% | 6.9% | 1.8% | 1.2% | 1.4% | 2.6% | 3.1% | 2.3% | -15.2% | 4.4% | |
| 11.3% | 21.7% | 6.7% | 1.7% | 7.7% | 11.6% | 13.0% | 16.4% | 15.9% | 14.3% | 31.9% | 14.7% | |
| 20.5% | 23.7% | 14.7% | 22.4% | 22.5% | 24.8% | 26.0% | 28.2% | 27.2% | 26.4% | 25.8% | 26.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.